Regeneration Biomedical
Business Services · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3900 W Coast Hwy Ste 300, Newport Beach,...Phone Number
(877) 240-1660Revenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Regeneration Biomedical
Regeneration Biomedical, Inc. (RBI) is a clinical-stage company based in Newport Beach, CA, focused on developing innovative stem cell therapies for neurodegenerative diseases. With over 30 years of medical and research experience, RBI is advancing treatments through FDA-approved clinical trials, including a Phase 1 trial for Alzheimer's disease. The company utilizes Wnt-activated autologous stem cells injected directly into the brain to enhance regenerative processes and reduce inflammation. RBI aims to harness the power of patients' own cells to treat conditions such as ALS, multiple sclerosis, Parkinson's disease, stroke, and traumatic brain injury.Explore more
Popular Searchesregeneration biomedical IncSIC Code 87,873NAICS Code 54,541Show moreRegeneration Biomedical Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Regeneration Biomedical your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Regeneration Biomedical has new funding data
Check if Regeneration Biomedical has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Click to see if Regeneration Biomedical had a recent Job posting/layoffs
Earning: See what the market has to say on Regeneration Biomedical recently announced quarterly report
Regeneration Biomedical, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Regeneration Biomedical launches new products
Check out if Regeneration Biomedical is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Regeneration Biomedical
Recommended Actions
Reach out to Masked Content who joined Regeneration Biomedical as Masked Content
Find more new buyers
Compare Similar Companies to Regeneration Biomedical
Compare insights from companies similar to Regeneration Biomedical, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
11-50
Private
<$5M
2005
CL
Cynthia LevinthalPrincipal Consultant. Neural Stem Cell Therapies. Clinical Trials
Company Profile Activity
Activity Insights
Regeneration Biomedical is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Regeneration Biomedical is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Regeneration Biomedical.
Regeneration Biomedical Tech Stack
A closer look at the technologies used by Regeneration Biomedical
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Governmental Affairs & Regulation, Bioengineering, Medical Research, Pharmaceuticals, Clinical Operations, Regulations
Project
Product Management, Intellectual Property, Legal Affairs, Bioengineering, Pharmaceuticals
Regeneration Biomedical News & Media
Exclusive: Safe, Direct-to-Brain Autologous Stem Cell Therapy Shows Promise in Alzheimer’s
A Phase 1, "first-in-mankind" trial of stem cells injected directly into the brain, is safe with early signs of efficacy; FDA submission made for Phase 2 trial. NEWPORT BEACH, CA, UNITED STATES, August 25, 2025 /EINPresswire.com/ -- …Regeneration Biomedical to Present Updated Phase 1 Trial Data on Autologous Stem Cell Therapy Injected Directly into the Brain for Alzheimer’s Disease in Podium Presentation at the ISCT 2025 Scientific Annual Meeting
NEWPORT BEACH, Calif., May 05, 2025 (GLOBE NEWSWIRE) -- Regeneration Biomedical, Inc. (“RBI”), a clinical-stage company developing autologous stem cell therapies for neurodegenerative diseases, today announced that updated interim results from its ongoing Phase 1 clinical trial in Alzheimer’s disease (AD) will be featured in a podium presentation at the Scientific Annual Meeting of the International Society for Cell & Gene Therapy (ISCT) in New Orleans, taking place May 7-10, 2025.Regeneration Biomedical Presents Data on First Cohort from an Ongoing Phase I Clinical Trial of Stem Cell Therapy Delivered Directly into the Brains of Patients with Alzheimer’s Disease
NEWPORT BEACH, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Regeneration Biomedical, Inc. (“RBI”), a clinical-stage company developing autologous stem cell treatments for neurodegenerative diseases, today announced a presentation on the first dose cohort from a Phase 1 clinical trial of Wnt-activated, autologous, expanded, adipose-derived stem cells (RB-ADSCs) administered directly into lateral ventricles of the brain in patients with Alzheimer’s Disease (AD). The treatment was well tolerated. At 1Regeneration Biomedical to Present Data on First Two Subjects in a Phase I Clinical Trial of Stem Cell Therapy delivered directly into the brains of Patients with Alzheimer’s Disease
Wnt-activated, autologous, expanded, adipose-derived stem cells administered directly into lateral ventricles of the brain via Ommaya reservoir implanted under the scalp to bypass blood brain barrier
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Regeneration Biomedical
Sign Up For FreeTo access detailed company insights
Regeneration Biomedical, Inc. (RBI) is a clinical-stage company based in Newport Beach, CA, focused on developing innovative stem cell therapies for neurodegenerative diseases. With over 30 years of medical and research experience, RBI is advancing treatments through FDA-approved clinical trials, including a Phase 1 trial for Alzheimer's disease. T... Read More
